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Background: To evaluate the feasibility and additional diagnostic benefit of a high-resolution steady state
3D-volume interpolated breath-hold exam (VIBE) sequence between a continuous table movement (CTM) MR
angiography of the entire runoff vasculature and a time-resolved (TWIST) MRA of the calves.
Methods: In this retrospective IRB approved study 224 patients (72 women, 152 men, mean age 67.29 ± 13.9) were
included who had undergone a low-dose MR angiographic protocol at 3T (Siemens TimTrio) after injection of 0.1
mmol/kg gadobutrol including a CTM MRA, a time-resolved MRA of the calf station and a steady state 3D VIBE
sequence prior to the time-resolved MRA. One board-certified radiologist rated the image quality of the steady
state VIBE sequences on an ordinal three point scale (excellent, good, poor) and analyzed the images for additional
diagnostic findings of and beyond the vascular system in comparison to the CTM MRA and the time-resolved MRA.
Descriptive statistics and demographic patient data were used for further evaluation.
Results: The image quality of the steady state imaging of the pelvis, upper and lower leg was excellent in up to
88%, 84% and 47%, respectively, while poor image quality was only detected in the upper (2%) and lower leg (6%).
An additional diagnostic benefit was found in 44% of the patients overall. The most common relevant pathologies
included inflammatory processes of the soft tissues (26%), thrombi (14%), abscesses (13%) and tumors (11%). In
subgroups of patients above the age of 60, 65, 70, 75 and 80 years an additional pathology was found in 50% 33%,
44%, 65% and 58%, respectively. There was no significant difference in terms of additional findings between men
and women (46% and 39%, p > 0.05) and inpatients and outpatients (42% and 45%, p > 0.05).
Conclusion: Steady state imaging is also feasible with extracellular contrast agents with good image quality
yielding additional diagnostic findings in up to 44% and above in patients older than 60 years of age irrespective
of gender or patient status. Given the short acquisition time of 4 minutes this sequence could be added to all
peripheral MRA exams.
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Table 1 Characteristics of the study population
Patient count 224
Mean age (years) 67.29
SD (years) ± 13.9
Age range (years) 15 - 95
Men 152
Women 72
CTM MRA 
0.07 mmol/kg 
62 seconds 
Steady State 3D VIBE  
1:26 min Tacq/station 
TWIST MRA 
0.03 mmol/kg 
96 seconds  
Figure 1 Graphic depiction of the MRA protocol and the order
of the acquisition.
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Several imaging modalities allow for the depiction of the
vascular anatomy of patients with peripheral arterial
occlusive disease (PAOD). Digital subtraction angiography
(DSA) has been the gold standard method [1], but it
involves iodinated and potentially nephrotoxic contrast
agents as well as ionizing radiation and the accompanied
risks. In addition, DSA is expensive and invasive com-
pared to other imaging methods. Significant complications
such as hemorrhage or emboli following peripheral DSA
occur in approximately 2% [2].
In contrast, computed tomography angiography (CTA)
is a minimally invasive imaging method with a shorter
examination time while maintaining a high diagnostic
accuracy [3]. As in DSA, CTA is also limited by poten-
tially nephrotoxic contrast agents, decreased diagnostic
accuracy in heavily calcified vessels, use of ionizing radi-
ation and its limited soft tissue contrast [4].
Peripheral contrast enhanced (CE)-MRA has been
proven as the method of choice for non-invasive imaging
of the vasculature without radiation exposure or nephro-
toxic contrast agents while maintaining high diagnostic
accuracy [5]. The basic technique employed for periph-
eral CE-MRA is the bolus-chase method which involves
intravenous injection of a paramagnetic MR contrast
agent and acquisition of T1-weighted images in the sub-
sequent arterial first-pass phase [6]. In order to achieve
high quality MR angiograms without interfering venous
contamination or artifacts optimization of peripheral
CE-MRA by implementing hybrid scan protocols have
been proposed and proven to be feasible [7-9]. This
involves a separate injection of contrast media to image
the calf region for a time-resolved MRA to safely depict
this critical vascular territory and to increase the diag-
nostic accuracy [10].
At our site a low-dose MR angiographic protocol that
consists of a continuous table movement MRA (CTM-
MRA) of the entire runoff vasculature with 0.07 mmol/kg
Gd-chelate and a time-resolved MRA with stochastic
interleaved trajectories (TWIST-MRA) of the calf station
with 0.03 mmol/kg Gd-chelate as described in the litera-
ture is being followed [8]. Additionally, a high-resolution
steady state 3D-volume interpolated breath-hold exam
sequence was introduced prior to the time-resolved MRA
with two aims: make positive use of the time delay
between the CTM-MRA and the TWIST-MRA and to be
able to assess extra-vascular and venous structures more
closely. Steady-state imaging is a concept in CE-MRA that
offers depiction of both arteries and veins – yet so far,
steady state imaging has only been performed after the
application of intravascular contrast agents such as gado-
fosveset [11-13].
Up until now there has been no research pursued regar-
ding the feasibility of steady state imaging with injection ofgadobutrol – an extracellular contrast agent – and the
additional vascular and non-vascular pathology found in
this kind of imaging. Therefore, the aim of this study was
to assess the feasibility of such imaging and to investigate if
specific subgroups of patients show a greater benefit from
steady state imaging.
Methods
This retrospective single-center study was pursued
without any financial support from industry. The
authors had complete control of the data submitted for
publication. This study was approved by our local ethics
Figure 2 Coronal MIP-images of a 44-year-old woman without any pathologies. (a) Conventional MRA. (b) Steady-state 3D VIBE sequence
Table 2 Results of image analysis
Image quality score Pelvis % Upper leg % Lower leg %
3 187 88.2 185 84 104 47.3
2 24 11.3 33 14.8 102 46.4
1 1 0.5 4 1.8 14 6.4
Total 212 100 222 100 220 100
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cine Mannheim, Ruprecht-Karls-University Heidelberg),
reference number 2008-338N-MA and pursued in compli-
ance with the Helsinki Declaration. Due to its retrospect-
ive nature of our study informed consent has been waived
and all data has been analysed anonymously.
Patients
Two hundred and twenty-four consecutive patients who
had undergone a peripheral MRA exam between January
2010 and May 2012 were included in this retrospective
study. The characteristics of the study population are
listed in Table 1.Further analysis included extraction of the patients
clinical information out of the clinical information
system (ISH-Med, SAP, Walldorf, Germany) concerning
the following risk factors: hypertension, hyperlipidemia,
smoking and diabetes.
(a) (b)
Figure 3 Coronal images of a 42-year-old man. (a) Conventional MRA. (b) Steady-state 3D VIBE sequence showing a thrombus in the right
superior femoral vein (box).
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MRA examinations were performed on a 3.0T MR scan-
ner (Magnetom TimTrio; Siemens Healthcare Sector,
Erlangen, Germany) using a dedicated matrix coil with
36 independent coil elements and two 6-element body
matrix coils for signal reception in addition to two clus-
ters of the built-in 32-element spine matrix. Patients
were positioned feet first supine. The low-dose MRA
protocol consisted of a CTM-MRA (TR/TE, 2.4/1.0 ms;
21° flip angle; 1.2 mm isotropic; gadolinium dose 0.07
mmol/kg BW), a time-resolved (TWIST) MRA of the
calf station (TR/TE 2.8/1.1 ms; 20° flip angle; 1.1 mm
isotropic; 5.5s temporal resolution; gadolinium dose 0.03
mmol/kg BW) and a steady state 3D VIBE sequence
(TR/TE 3.8/1.2 ms; 12.5° flip angle; 1.3 mm isotropic;
PAT 3) prior to the time-resolved MRA. The steady state(a)
Figure 4 Coronal images of a 69-year-old man. (a) Conventional MRA.
psoas muscle (box).MRA was acquired in three steps (pelvis, thighs, calves)
and composed afterwards to yield a single large field of
view. The timing of the sequences is shown in Figure 1.
An example of coronal MIP-images of a CTM MRA and
a steady state 3D VIBE sequence of a healthy woman
without any pathologies is shown in Figure 2.
Contrast agent
For this study gadobutrol (1.0 M Gadovist®; Bayer Health-
care, Berlin, Germany), a gadolinium-based, macrocyclic,
paramagnetic contrast agent was administered in the
abovementioned protocol. A cumulative dose of 0.1
mmol/kg (1.0 mol/L; 0.07 mmol/kg for CTM MRA, 0.03
mmol/kg for TWIST MRA) was used. For equalization of
injection volumes gadobutrol was diluted with saline
in a 1:1 ratio. Contrast agent was injected at a rate of(b)
(b) Steady-state 3D VIBE sequence showing an abscess in the left
(a) (b) (c) (d) (e)
Figure 5 Coronal images of an 84-year-old man. (a, b, d) Conventional MRA. (c, e) Steady-state 3D VIBE sequence showing a non-contrast-
enhanced aneurysm (box).
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cubital vein by using an automated power injector
(Spectris Solaris EP; Medrad, Indianola, PA). Subse-
quently, an injection of a 30-mL saline bolus was
administered at the same injection rate.
Image analysis of MRA
One board-certified radiologist (blinded, >10 years of ex-
perience in vascular imaging) performed image analysis
of the steady state MRA including pelvis, upper and
lower leg regions offline with an OsiriX DICOM viewer
3.8.1 (OsiriX Foundation, Geneva, Switzerland). Overall
image quality was analyzed on a three point scale (3:
excellent image quality allowing assessment of arteries,
vessels and soft tissue; 2: good image quality allowing
impaired assessment of arteries, vessels and soft tissue;2 2 
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Figure 6 Age distribution of the study population.1: poor image quality not allowing sufficient assessment
of the vascular and/or soft tissue structures). The
presence of additional diagnostic findings of the vascular
system and beyond was noted. All findings which could
not be seen on either the CTM-MRA or the TWIST-
MRA were considered to represent additional findings.
Statistical analysis
Descriptive statistics (median, mean, 95% confidence
interval and standard deviation (SD)) were used for all
data including evaluation of overall image quality, addi-
tional diagnostic findings, as well as patient status and
demographic patient data. A Wilcoxon rank sum test was
used to analyze a relation between age and additional
pathology. Relationship between specific risk factors and
additional pathology was analyzed by chi-square test. The26 
24 
32 
31 
24 
13 
4 
-65 -70 -75 -80 -85 -90 -95 
groups
Table 3 Results of gender analysis
Additional
pathology
No additional
pathology
Total %
Male 70 82 152 68
Female 28 44 72 32
Total 98 126 224 100
Table 4 Results of patient status analysis
Additional
pathology
No additional
pathology
Total %
Outpatient 41 50 91 41
Inpatient 56 76 132 59
Total 97 126 223 100
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value was no greater than 0.05. SAS statistical software
(SAS 9.2 TS Level 2M3, 2012, SAS Institute Inc., Cary,
NC, USA) was used for statistical analysis.
Results
Image quality
Steady state imaging was successfully performed in all
patients. Image quality in the pelvic region was rated as
excellent in 187 (88%) of 212 cases, good in 24 (11%)
cases and poor in one case. Further results showed 185
(84%) out of 222 with excellent, 33 (15%) with good and
4 (2%) with poor image quality for the upper leg, as well
as 104 (47%) out of 220 with excellent, 102 (46%) with
good and 14 (6%) with poor image quality ratings for the
lower leg (Table 2). The main reason for image degrad-
ation were motion and particularly for the calves insuffi-
cient spatial resolution to clearly separate the arteries
from the veins. 12 data-sets for the pelvic region, 2 for
the upper leg region and 4 for the lower leg region were
not analyzed due to missing data in the PACS.
Pathologies
Osteochondrosis, joint and muscle infections were
included under inflammatory processes, which shared
26% of the additionally found pathologies. Bursitis of the
trochanter was detected in 17%, varicosis and thrombi
(Figure 3) in 14% each, abscesses (Figure 4) in 13%,
tumors in 11% (e.g. osseous metastases, bladder cancer)
and synovitis of the knee in 9%. Further pathologies
which accounted for less than 5% included wall thick-
ening of the sigmoid, arterial emboli, arterial aneu-
rysms (Figure 5), varicoceles, phlegmons and occluded
bypasses.
Age
In the subgroup of patients with the age of up to 60
years additional pathology could be found in 50%, in the
subgroups with the age up to 70, 75, 80, 85 and 90,
additional pathology was found in 33%, 44%, 65%, 58%
and 46%, respectively. The age distribution of the patient
cohort is shown in Figure 6.
Gender
No significant difference with respect to additional path-
ology could be found based on gender using a chi-square
test: 70 (46%) out of a total of 152 male patients compared
to 28 (39%) out of 72 female patients showed an additional
pathology in the added steady state 3D-VIBE sequence
(p > 0.05) (Table 3).
Patient status
No significant difference with respect to additional path-
ology could be found based on patient status using achi-square test: 41 (45%) out of a total of 91 outpatients
compared to 56 (42%) out of 132 inpatients patients
showed an additional pathology in the added steady state
3D-VIBE sequence (p > 0.05) (Table 4).
Risk factors
Patient data was analyzed concerning risk factors for
peripheral arterial occlusive disease. Out of the total of
224 patients 195 had sufficient clinical information
about risk factors including hypertension, hyperli-
pidemia, smoking and diabetes. 85% of those patients
suffered from hypertension, whereas 54% suffered from
hyperlipidemia. 46% in each group showed relevant
additional pathologies in the steady state VIBE sequence.
49% and 47% of the patient cohort smoked and suffered
from diabetes, respectively. 42% in each group (smoking/
diabetes) showed relevant additional pathologies (Figure 7).
Statistical analysis could not show any significant relation
between risk factors and additional pathologies.
Patient data confirming PAOD existed for 196 patients.
For 140 patients information about the specific PAOD-
stage was available. With a total of 78 patients stage II was
represented the most, followed by 51 patients classified as
stage IV, 10 patients as stage III and merely one patient as
stage I (Figure 8).
Discussion
Over the past 5 years MRA has undergone substantial
improvements including high image quality and high
diagnostic accuracy at low amounts of Gd-chelate
[14,15]. For patients with peripheral arterial occlusive
disease (PAOD) contrast-enhanced MRA has become
the most appropriate noninvasive diagnostic method of
choice [16]. Systematic reviews have confirmed the high
diagnostic accuracy of peripheral CE-MRA [5].
Conventional peripheral CE-MRA is based on a bolus-
chase method which involves imaging over three stations
from the aortic bifurcation to the periphery after single-
46 46 
42 42 
85 
54 
49 47 
Hypertension Hyperlipidemia Smoking Diabetes 
Risk factors 
Additional pathology No additional pathology 
Figure 7 Patients with the following risk factors of peripheral arterial occlusive disease (PAOD): hypertension, hyperlipidemia, smoking
and diabetes respective to showing an additional pathology in the added steady-state-VIBE sequence (%).
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contamination of the lower leg region particularly in
patients with higher stages of PAOD and concomitant
risk factors [17]. To overcome venous contamination in
order to maintain high diagnostic accuracy for every
station, new techniques have been developed such as the
hybrid scan protocol which can be performed by two
different ways: a large field-of-view MRA after the first
injection of contrast agent followed by a time-resolved
(TWIST) MRA of the calf station after the second injec-
tion or by scanning the peripheral region first followed
by the pelvic/thigh region after the second injection of
contrast media [9,18]. Both techniques have specific
advantages but both have a time delay between the two
contrast agent injections in common. This time delay
was filled with the acquisition of a steady state MRA at
our institution aiming at the detection of additional –
particularly extra-vascular – pathology. Due to the time
lag between the CTM and TWIST MRA there is almost
no significant time loss by implementing the steady state
VIBE sequence. Up until now, there has been no re-
search pursued concerning the impact and occurrencen = 224 
n = 196 PAOD 
n = 28  
n/a data 
Figure 8 Flow diagram showing the number of patients with specificof additional pathology in steady state imaging: initial
steady state imaging with intravascular contrast agents
was not suited for the detection of extra-vascular
pathologies and steady state imaging with extracellular
contrast agents has not been attempted or at least
not been published. This led to initiating the present
retrospective study.
This study has proven that by implementing a steady
state VIBE sequence in a routine MRA, relevant add-
itional pathology can be acquired with good image qual-
ity that allows identification of additional pathologic
findings without added injection of contrast media and
with almost no time loss. In contrast to our initial
assumptions, the presence of additional pathology was
found irrespective of gender or patient status. We eva-
luated the incidence of risk factors for PAOD such as
hypertension, hyperlipidemia, smoking and diabetes
[19,20]. The results of our study could not show an
increased number of additional pathologies in patients
with the aforementioned risk factors for PAOD. There
was no difference in the incidence of additional path-
ology between inpatients and outpatients either. Thisn= 140  
PAOD stage  
n = 1 
Stage I 
n = 78 
Stage II 
n = 10 
Stage III 
n = 51 
Stage IV 
n = 56  
stage n/a 
stages of peripheral arterial occlusive disease (PAOD).
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was expected in inpatients. The additional pathologies
included a wide range of diseases: from less important
findings such as bursitis (17%) to relevant pathologies that
required medical attention and treatment such as deep
venous thrombi (14%), soft tissue abscesses (13%) and
malignant tumors (11%).
Our findings concur with a previous publication that
has used the intravascular contrast agent gadofosveset
which thus implicate a blood pool role for extracellular
contrast agents such as Gadobutrol. Hadizadeh et. al
have investigated the prevalence of incidental deep
venous thrombosis (DVT) in patients with clinically
suspected PAOD who had undergone CE-MRA on a
1.5T scanner. Similar to our sample size 245 patients
were included. Incidental DVT was observed in 11%,
comparable to our results with 14% of incidental
thrombi [21]. The image quality of the steady state VIBE
images tended to be worse at the calf station in our
study. This was due to the limited spatial resolution that
did not always allow separating arteries and veins. A
previous study using gadofosveset demonstrated that a
spatial resolution of 0.5 mm isotropic was necessary to
safely identify arterial and venous structures [13].
Study limitations
Since this study was conducted as a retrospective ana-
lysis of peripheral MRA at our institution not all of the
clinical information for each patient could be retrieved.
The influence of additionally found pathologies with
regard to possible changes in patient care has not yet been
analyzed. However, the main goal of our study was to
quantify additional pathology found, as well as analysis
regarding patient characteristics including risk factors.
Therefore, further investigation concerning therapeutic
management changes have not been part of this study.
Future studies will be needed to assess the true clinical
value of applying steady state VIBE sequences in patients
who undergo a peripheral MRA. Given that all of the
examinations were scanned on a 3T scanner where the
contrast agent efficacy is higher than at 1.5T results may
not be transferable to a 1.5T scanner [22]. Theoretically,
the protocol used for this study can be implemented on a
1.5T scanner.
Conclusion
Our study has shown that steady state 3D VIBE imaging
with extracellular contrast agents is feasible with good
image quality and additional diagnostic findings in 44%
and above in patients older than 60 years irrespective of
gender or patient status.
Without additional contrast media application or sig-
nificant time loss, steady state imaging may further
improve the diagnostic value of peripheral MRA.Competing interests
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